0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Evidence for a Cyclic Guanosine Monophosphate—Dependent, Carbon Monoxide—Mediated, Signaling System in the Regulation of TNF-α Production by Human Pulmonary Macrophages

Javier Arias-Díaz, MD, PhD; Elena Vara, PhD; Cruz Garcia, PhD; Natividad Villa; Jose L. Balibrea, MD, PhD
Arch Surg. 1995;130(12):1287-1293. doi:10.1001/archsurg.1995.01430120041006.
Text Size: A A A
Published online

Background and Objectives:  The second messenger cyclic guanosine 3′,5′-monophosphate (cGMP) seems to be implicated in the release of tumor necrosis factor α (TNF-α) by activated macrophages. There is controversy regarding the potential of human macrophages to produce nitric oxide (NO). Since guanylate cyclase can be activated also by carbon monoxide (CO) and this gas may be formed endogenously, we examined the ability of human pulmonary macrophages to produce CO in the presence of lipopolysaccharide (LPS) or LPS+interferon gamma (IFN-γ). In addition, the source and the relative contribution of this molecule to the LPS-induced increase in cell cGMP content and TNF-α release were explored.

Design:  Interstitial macrophages were obtained from multiple organ donor lungs by enzymatic digestion. After 24-hour preculture, purified macrophages were cultured for 24 hours in the presence or absence of LPS, LPS+IFN-γ, CO (250 and 500 μmol/L), sodium nitroprusside, 8-Br-cGMP, hemoglobin, methylene blue, zinc-protoporphyrin IX, hemin, S-adenosylmethionine, deferoxamine mesylate, or combinations. The cGMP content of the cells and TNF-α, CO, and NO release to the medium were determined.

Results:  In the presence of LPS, TNF-α production was not accompanied by any detectable increase in the NO release to the medium. However, an increase in medium CO concentration (mean±SEM) (5.81±0.20 vs 3.74±0.08 pmol/μg protein; n=11; P<.01) and cell cGMP content (0.273±0.021 vs 0.138±0.019 pmol/μg protein; n=10; P<.01) was observed. These changes were more pronounced in the presence of LPS+IFN-γ. Release of TNF-α also was induced by both sodium nitroprusside and 8-Br-cGMP. In contrast, methylene blue, a guanylate cyclase inhibitor, inhibited LPS-, LPS+IFN-γ−, and sodium nitroprusside–induced TNF-α production and cGMP increase; hemoglobin, which traps CO, had a similar effect.

Conclusion:  Intracellular cGMP increase, secondary to an endogenous production of CO, participates in the release of TNF-α by activated human pulmonary macrophages.(Arch Surg. 1995;130:1287-1293)

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();